Epivario Inc

From the company

EpiVario Inc. is an innovation-focused biotechnology company spun out of the Epigenetics Institute of the University of Pennsylvania. It develops neuroepigenetic modulators and pharmacotherapeutics targeting a newly discovered epigenetic process in long-term memory, aiming to treat memory-related addiction and psychiatric disorders including PTSD, opioid use disorder, alcohol use disorder, and nicotine use disorder. Its cofounders discovered the metabolic enzyme ACSS2, and the company is developing a proprietary small molecule inhibitor of ACSS2.